Products
-
High Purity Peptides Retatrutide 10mg for Weight Loss and Diabetes
Purity: >99%
State: Lyophilized Powder
Appearance: White powder
Specification: 5mg/10mg/15mg/20mg/30mg
-
Retatrutide
Retaglutide is a new dipeptidyl peptidase-4 (DPP-4) inhibitor class hypoglycemic drug that can prevent the degradation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulin-releasing polypeptide (GIP) by DPP-4 enzyme in the intestine and blood, prolonging their activity, thereby promoting insulin secretion by pancreatic β cells without affecting the basal level of fasting insulin, while reducing the secretion of glucagon by pancreatic α cells, thereby more effectively controlling postprandial blood sugar. It performs well in terms of hypoglycemic effect, tolerance, and compliance.
-
Inclisiran sodium
Inclisiran sodium API (Active Pharmaceutical Ingredient) is studied primarily in the field of RNA interference (RNAi) and cardiovascular therapeutics. As a double-stranded siRNA targeting the PCSK9 gene, it is used in preclinical and clinical research to evaluate long-acting gene-silencing strategies for lowering LDL-C (low-density lipoprotein cholesterol). It also serves as a model compound for investigating siRNA delivery systems, stability, and liver-targeted RNA therapeutics.
-
Fmoc-Gly-Gly-OH
Fmoc-Gly-Gly-OH is a dipeptide used as a basic building block in solid-phase peptide synthesis (SPPS). It features two glycine residues and an Fmoc-protected N-terminus, allowing for controlled peptide chain elongation. Due to glycine’s small size and flexibility, this dipeptide is often studied in the context of peptide backbone dynamics, linker design, and structural modeling in peptides and proteins.
-
Fmoc-Thr(tBu)-Phe-OH
Fmoc-Thr(tBu)-Phe-OH is a dipeptide building block commonly used in solid-phase peptide synthesis (SPPS). The Fmoc (9-fluorenylmethyloxycarbonyl) group protects the N-terminus, while the tBu (tert-butyl) group protects the hydroxyl side chain of threonine. This protected dipeptide is studied for its role in facilitating efficient peptide elongation, reducing racemization, and modeling specific sequence motifs in protein structure and interaction studies.
-
AEEA-AEEA
AEEA-AEEA is a hydrophilic, flexible spacer commonly used in peptide and drug conjugation research. It consists of two ethylene glycol-based units, making it useful for studying the effects of linker length and flexibility on molecular interactions, solubility, and biological activity. Researchers often use AEEA units to evaluate how spacers influence the performance of antibody-drug conjugates (ADCs), peptide-drug conjugates, and other bioconjugates.
-
![Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA]-OH](https://cdn.globalso.com/gentolexgroup/Glepaglutide10-300x300.png)
Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA]-OH
This compound is a protected, functionalized lysine derivative used in peptide synthesis and drug conjugate development. It features an Fmoc group for N-terminal protection, and a side-chain modification with Eic(OtBu) (eicosanoic acid derivative), γ-glutamic acid (γ-Glu), and AEEA (aminoethoxyethoxyacetate). These components are designed to study lipidation effects, spacer chemistry, and controlled drug release. It is widely researched in the context of prodrug strategies, ADC linkers, and membrane-interacting peptides.
-
![Fmoc-L-Lys[Ste(OtBu)-γ-Glu-(OtBu)-AEEA-AEEA]-OH](https://cdn.globalso.com/gentolexgroup/Glepaglutide9-300x300.png)
Fmoc-L-Lys[Ste(OtBu)-γ-Glu-(OtBu)-AEEA-AEEA]-OH
This compound is a modified lysine derivative used in peptide synthesis, particularly for constructing targeted or multifunctional peptide conjugates. The Fmoc group allows for stepwise synthesis via Fmoc solid-phase peptide synthesis (SPPS). The side chain is modified with a stearic acid derivative (Ste), γ-glutamic acid (γ-Glu), and two AEEA (aminoethoxyethoxyacetate) linkers, which provide hydrophobicity, charge properties, and flexible spacing. It is commonly studied for its role in drug delivery systems, including antibody-drug conjugates (ADCs) and cell-penetrating peptides.
-
Liraglutide Anti-Diabetics for Blood Sugar Control CAS NO.204656-20-2
Active Ingredient: Liraglutide (analog of human glucagon-like peptide-1 (GLP-1) produced by yeast through genetic recombination technology).
Chemical Name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
Other Ingredients: Disodium Hydrogen Phosphate Dihydrate, Propylene Glycol, Hydrochloric Acid and/or Sodium Hydroxide (as pH Adjusters Only), Phenol, and Water for Injection.
-
Leuprorelin Acetate Regulates Secretion of Gonadal Hormones
Name: Leuprorelin
CAS number: 53714-56-0
Molecular formula: C59H84N16O12
Molecular weight: 1209.4
EINECS Number: 633-395-9
Specific rotation: D25 -31.7° (c = 1 in 1% acetic acid)
Density: 1.44±0.1 g/cm3(Predicted)
-
Boc-His(Trt)-Aib-Gln(Trt)-Gly-OH
Boc-His(Trt)-Aib-Gln(Trt)-Gly-OH is a protected tetrapeptide used in peptide synthesis and structural studies. The Boc (tert-butyloxycarbonyl) group protects the N-terminus, while Trt (trityl) groups protect the side chains of histidine and glutamine to prevent unwanted reactions. The presence of Aib (α-aminoisobutyric acid) promotes helical conformations and enhances peptide stability. This peptide is valuable for investigating peptide folding, stability, and as a scaffold for designing biologically active peptides.
-
BPC-157
BPC-157 API adopts solid phase synthesis (SPPS) process:
High purity: ≥99% (HPLC detection)
Low impurity residue, no endotoxin, no heavy metal pollution
Batch stability, strong repeatability, support injection level use
Support gram and kilogram level supply to meet the needs of different stages from R&D to industrialization.